Extended Paxlovid courses show mixed results for long COVID symptoms

A study indicates that longer Paxlovid treatments could improve long COVID symptoms in some patients, highlighting the need for tailored antiviral strategies.

Mediterranean Diet Tied to Lower Mortality Risk in Cancer Survivors

Long-term cancer survivors tended to live longer if they consumed a Mediterranean diet, analysis of an Italian cohort study found. With a follow-up of almost

July 7, 2024

In pivot to buzzy ADCs, London biotech Myricx raises $114M with Lilly’s support

On the verge of raising its Series A in late 2021, Myricx Bio faced a tough choice. The toxicity profile for its IV and oral

July 8, 2024

Pediatric Neuron Disease Gets Its First Gene Therapy

The FDA approved atidarsagene autotemcel (arsa-cel; Lenmeldy), the first gene therapy to treat children with pre-symptomatic late infantile, pre-symptomatic early juvenile, or early symptomatic early

March 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.